Biospring Gesellschaft Fur Biotechnologie Mbh

Where the EU money came from

Funding by EU programme. Amounts are Biospring Gesellschaft Fur Biotechnologie Mbh's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• MIRACLEPartner

  Novel tumor-selective lethal miRNAs for the treatment of head and neck cancer

  FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

  €182ktheir share
• SCOPE-DMDPartner

  Consortium for Products across Europe in Duchenne Muscular Dystrophy

  FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

  €1.3Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Stichting VuNetherlands · 1 shared project
• Academisch Ziekenhuis LeidenNetherlands · 1 shared project
• Stichting Amsterdam UmcNetherlands · 1 shared project
• University of Newcastle Upon TyneUnited Kingdom · 1 shared project
• Polymun Scientific Immunbiologische Forschung GmbHAustria · 1 shared project
• Biomarin Nederland BVNetherlands · 1 shared project
• Association Institut de MyologieFrance · 1 shared project
• Interna Technologies BVNetherlands · 1 shared project
• Quiet Therapeutics LtdIsrael · 1 shared project
• InnovacentricBelgium · 1 shared project
• Octoplus NVNetherlands · 1 shared project
• Lpt Laboratory of Pharmacology and Toxicology GmbH & Co KGGermany · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• RNA
• duchenne muscular dystrophy
• head and neck cancer
• mutation
• proteins